June 10, 2025: Taking Ozempic Doubles a Persons Risk of a Type of Vision Loss The European Medicines Agency (EMA) has concluded that taking Ozempic doubles a persons risk of developing a type of vision loss called nonarteritic anterior ischemic optic neuropathy or NAION
The recommended starting dose is 2.5 mg once weekly
In an essay that she penned for The Free Press titled "My GLP-1 Nightmare," the 50-year-old actress admitted that she had grappled with body image issues since she was a teenager but emphasized that weight loss was not her primary reason for taking the medication
For example, across Europe, national health authorities are conducting detailed health technology assessments to determine whether incretin-based drugs provide sufficient clinical benefit relative to their cost
Cagrilintide: How much weight can you lose
Journal of Clinical Oncology , 30(19), pp.23142326